Sort
16,300 grants matching “fatty liver disease”
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study (Other IC Supplement)
$78,309Stephen John Gange · Johns Hopkins University · U01 · FY2019 · HL
Anti-inflammatory actions of a novel hemin-induced electrophile in Sickle Cell Disease
$78,250Dario A Vitturi · University Of Pittsburgh At Pittsburgh · R03 · FY2021 · HL
Determination of the Microbiome of Growth Restricted Mice
$78,250David Paul Ferguson · Michigan State University · R03 · FY2022 · HD
Determination of the Microbiome of Growth Restricted Mice
$78,250David Paul Ferguson · Michigan State University · R03 · FY2021 · HD
Mechanisms of Insulin Resistance in Man
$78,163Robert A. Rizza · Mayo Clinic Rochester · R01 · FY2010 · DK
HEG1 as a regulator of hypertension and atherosclerosis
$78,040Michael David Clark · Emory University · F32 · FY2025 · HL
Understanding mechanisms by which microbially derived metabolites regulate host gut inflammation.
$78,040Elektra Kantzari Robinson · Stanford University · F32 · FY2025 · DK
Role of Dietary Cholesterol in Alcoholic Steatohepatitis and Insulin Resistance
$78,000Lin Jia · University Of Texas Dallas · R03 · FY2022 · AA
Continuation of the Non-Alcoholic Steatohepatitis Clinical Research Network (NASH
$78,000James A Tonascia · Johns Hopkins University · U01 · FY2010 · DK
THE ALTERED PROTEIN METABOLISM OF PEDIATRIC PATIENTS WITH HIV INFECTION
$77,993Farook Jahoor · Baylor College Of Medicine · M01 · FY2009 · RR
Xenobiotic-responsive hepatic long non-coding RNAs
$77,783David J Waxman · Boston University (Charles River Campus) · R01 · FY2023 · ES
Xenobiotic-responsive hepatic long non-coding RNAs
$77,783David J Waxman · Boston University (Charles River Campus) · R01 · FY2024 · ES
Role of Th2 CD4 T Cells in Schistosoma Pulmonary Hypertension
$77,750Brian Barkley Graham · University Of Colorado Denver · R03 · FY2017 · HL
Role of Th2 CD4 T Cells in Schistosoma Pulmonary Hypertension
$77,750Brian Barkley Graham · University Of Colorado Denver · R03 · FY2016 · HL
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.
$77,500Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2014 · HD
Epigenetics of Obesity and Insulin Resistance
$77,500Jane Kim · University Of California, San Diego · R03 · FY2014 · DK
Advanced NMR/MRI Methods for Liver Cancer
$77,500Yasvir Avindra Tesiram · Oklahoma Medical Research Foundation · R03 · FY2008 · CA
Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
$77,402Ruth E. Stark · City College Of New York · R16 · FY2025 · GM
Histone methyltransferase G9a in liver pathophysiology and carcinogenesis
$77,358Hong Lu · Upstate Medical University · R03 · FY2011 · CA
Lipogenic inhibitors in prevention of oncogene induced liver cancer
$77,250Xin Chen · University Of California, San Francisco · R03 · FY2012 · CA
Keystone Meetings on the Cellular and Molecular Basis of Metabolic Disorders
$77,195Andrew D Robertson · Keystone Symposia · R13 · FY2007 · DK
Role of Dietary Cholesterol in Alcoholic Steatohepatitis and Insulin Resistance
$77,125Lin Jia · University Of Texas Dallas · R03 · FY2021 · AA
TORS - Interdisciplinary Research Training Program, Project 8 of 10 TL1
$77,081Joyce J Repa · Ut Southwestern Medical Center · TL1 · FY2009 · DK
Examining the role of a GCKR polymorphism in alcohol-related behaviors in mice
$77,000Marissa A Ehringer · University Of Colorado · R03 · FY2019 · AA
Role of Cathelicidin in Obesity and Diabetes
$77,000Hon Wai Koon · University Of California Los Angeles · R03 · FY2015 · DK